How long is it advisable to prolong maintenance treatment of patients with ulcerative colitis?
作者信息
Ardizzone Sandro, Porro Gabriele Bianchi
机构信息
Department of Gastroenterology, L. Sacco University Hospital, Milan, Italy.
出版信息
Inflamm Bowel Dis. 2008 Oct;14 Suppl 2:S238-9. doi: 10.1002/ibd.20671.
PMID:18816705
Abstract
摘要
相似文献
1
How long is it advisable to prolong maintenance treatment of patients with ulcerative colitis?溃疡性结肠炎患者维持治疗适宜延长多长时间？
Inflamm Bowel Dis. 2008 Oct;14 Suppl 2:S238-9. doi: 10.1002/ibd.20671.
2
[Mesalazine in ulcerative colitis. Fewer cases of colorectal carcinoma].[美沙拉嗪治疗溃疡性结肠炎。结直肠癌病例减少]
MMW Fortschr Med. 2002 Feb 28;144(9):51.
3
Chemoprevention of colorectal neoplasia in ulcerative colitis: the effect of 6-mercaptopurine.溃疡性结肠炎中结直肠肿瘤的化学预防：6-巯基嘌呤的作用
Clin Gastroenterol Hepatol. 2006 Apr;4(4):521; author reply 521. doi: 10.1016/j.cgh.2005.12.030.
4
What is the optimal maintenance treatment for ulcerative colitis?溃疡性结肠炎的最佳维持治疗方法是什么？
Inflamm Bowel Dis. 2008 Oct;14 Suppl 2:S236-7. doi: 10.1002/ibd.20670.
5
[5-aminosalicylic acid and cancer prophylaxis?].[5-氨基水杨酸与癌症预防？]
Ugeskr Laeger. 2006 May 22;168(21):2047.
6
[Chronic inflammatory bowel diseases. Recurrence prevention = carcinoma prevention?].[慢性炎症性肠病。预防复发 = 预防癌症？]
MMW Fortschr Med. 2005 Mar 31;147(13):10.
7
Mesalamine in the treatment and maintenance of remission of ulcerative colitis.美沙拉嗪治疗和维持溃疡性结肠炎缓解。
Expert Rev Clin Pharmacol. 2012 Mar;5(2):113-23. doi: 10.1586/ecp.12.2.
8
The role of chemoprevention of colorectal cancer with 5-aminosalicylates in ulcerative colitis.5-氨基水杨酸类药物在溃疡性结肠炎中的结直肠癌化学预防作用。
Dig Dis. 2012;30 Suppl 2:55-9. doi: 10.1159/000341894. Epub 2012 Nov 23.
9
Mesalamine in the Initial Therapy of Ulcerative Colitis.美沙拉嗪治疗溃疡性结肠炎的初步研究。
Gastroenterol Clin North Am. 2020 Dec;49(4):689-704. doi: 10.1016/j.gtc.2020.07.002. Epub 2020 Sep 25.
10
Balsalazide led to greater remission rates and tolerance than mesalamine in acute ulcerative colitis.在急性溃疡性结肠炎中，巴柳氮比美沙拉嗪有更高的缓解率和耐受性。
Gut. 1999 Apr;44(4):455. doi: 10.1136/gut.44.4.455.
引用本文的文献
1
Optimal Endpoint of Therapy in IBD: An Update on Factors Determining a Successful Drug Withdrawal.炎症性肠病治疗的最佳终点：决定药物成功撤药的因素更新。
Gastroenterol Res Pract. 2015;2015:832395. doi: 10.1155/2015/832395. Epub 2015 Jun 14.
2
Indian Society of Gastroenterology consensus on ulcerative colitis.印度胃肠病学会关于溃疡性结肠炎的共识
Indian J Gastroenterol. 2012 Dec;31(6):307-23. doi: 10.1007/s12664-012-0259-0. Epub 2012 Oct 25.
Zotero 插件